Skip to main content
. 2023 Jun 22;25(6):euad159. doi: 10.1093/europace/euad159

Table 3.

Base-case cost-effectiveness results stratified by device type

Population Incremental costs Incremental QALYs ICER (per QALY gained)
CRT-D €65 0.01 €6227
CRT-P €250 0.01 €29 177
Combined €118 0.01 €12 022